Cahill represented the underwriters in connection with a public offering of $600,000,000 aggregate principal amount of 4.300% senior notes due 2028 by Edwards Lifesciences Corporation.
Edwards Lifesciences Corporation is a medical equipment company specializing in hemodynamic monitoring and artificial heart valves.
Merrill Lynch, Pierce, Fenner & Smith Incorporated and J.P. Morgan Securities LLC acted as underwriters on the offering.
Proceeds from the offering were used to refinance existing indebtedness and for general corporate purposes.
O’Melveny & Myers LLP advised Edwards Lifesciences Corporation.
Cahill advised the underwriters with a team including William J. Miller (Picture), Alla Digilova and Jana L. Douglas.
Law Firms: Cahill Gordon & Reindel;